CaroGen Corp
About Us

CaroGen Highlights

AVIDIO Platform

Read More

Oncology: CARG-2020

Read More

Infectious Disease: CARG-201

Read More
CaroGen Corp
OUR TEAM

Senior Management and Founders

CaroGen Corp

Bijan Almassian, PhD

Co-Founder, President & CEO Board of Directors

CaroGen Corp

Deborah Church, MD

Chief Medical Officer

CaroGen Corp

John Rose, PhD

Co-Founder and Chairman of the SAB

CaroGen Corp

Michael Robek, PhD

Co-Founder, Member of SAB

OUR PRESS RELEASES

CaroGen News

CaroGen Corp

Dr Alvero on Antitumor Immunological Memory in Ovarian Cancer Models

Ayesha Alvero, MD, MSc, professor, Department of Obstetrics and Gynecology, Wayne State University School of Medicine, discusses findings from a preclinical study investigating the antitumor effects and recurrence prevention abilities of a virus-like vesicle thought to establish immunological memory in mouse models with ovarian cancer.

CaroGen Corp

Novel Immunomodulatory Virus CARG-2020 for Recurrent Ovarian Cancer

At the 2023 Society of Gynecological Oncology’s Annual Meeting on Women’s Cancer in Tampa, Florida, Ayesha Alvero, MD, C.S. Mott Center at Wayne State University, Detroit, Michigan, discusses the use of the novel immunomodulatory virus CARG-2020 to restore immunosurveillance and establish anti-tumoral immunological memory to prevent ovarian cancer recurrence.

CaroGen Corp

CaroGen’s CARG-2020 Preclinical Data on Ovarian Cancer Immunotherapy to be Presented Orally at the Society of Gynecologic Oncology Annual Meeting

CaroGen Corporation CaroGen Corporation (203) 815-5782 balmassian@carogencorp.com